Inadequate activation of the HBsAg-specific Th cells by APCs leads to hyporesponsiveness to HBsAg vaccine in B10.S mice

References

• Elgouhari HM, Abu-Rajab TT, Carey WD. Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis. Cleve Clin J Med 2008; 75:881-9; PMID:19088007; http://dx.doi.org/10.3949/ccjm.75a.07019
   PubMed Web of Science ®Google Scholar
• Busch K, Thimme R. Natural history of chronic hepatitis B virus infection. Med Microbiol Immunol 2014; 2014-1225; PMID:25540037
   PubMed Web of Science ®Google Scholar
• Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12:351-66; PMID:10194463
   PubMed Web of Science ®Google Scholar
• Han K, Shao X, Zheng H, Wu C, Zhu J, Zheng X, Zhang Y. Revaccination of non- and low- responders after a standard three dose hepatitis B vaccine schedule. Hum Vaccin Immunother 2012; 8:1845-9; PMID:22906933; http://dx.doi.org/10.4161/hv.21818
   PubMed Web of Science ®Google Scholar
• Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999; 179:489-92; PMID:9878036; http://dx.doi.org/10.1086/314578
   PubMed Web of Science ®Google Scholar
• Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, Ostrow DG, O'Malley PM, Penley KA, Altman NL. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986; 315:209-14; PMID:2941687; http://dx.doi.org/10.1056/NEJM198607243150401
   PubMed Web of Science ®Google Scholar
• Yan K, Cai W, Cao F, Sun H, Chen S, Xu R, Wei X, Shi X, Yan W. Genetic effects have a dominant role on poor responses to infant vaccination to hepatitis B virus. J Hum Genet 2013; 58:293-7; PMID:23486340; http://dx.doi.org/10.1038/jhg.2013.18
   PubMed Web of Science ®Google Scholar
• Duan Z, Chen X, Liang Z, Zeng Y, Zhu F, Long L, McCrae MA, Zhuang H, Shen T, Lu F. Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine. Vaccine 2014; 32:5316-22; PMID:25077417; http://dx.doi.org/10.1016/j.vaccine.2014.07.064
   PubMed Web of Science ®Google Scholar
• Yucesoy B, Talzhanov Y, Johnson VJ, Wilson NW, Biagini RE, Wang W, Frye B, Weissman DN, Germolec DR, Luster MI, et al. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations. Vaccine 2013; 31:5381-91; PMID:24075919; http://dx.doi.org/10.1016/j.vaccine.2013.09.026
   PubMed Web of Science ®Google Scholar
• Li ZK, Nie JJ, Li J, Zhuang H. The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis. Vaccine 2013; 31:4355-61; PMID:23887040; http://dx.doi.org/10.1016/j.vaccine.2013.06.108
   PubMed Web of Science ®Google Scholar
• Grzegorzewska AE, Pajzderski D, Sowinska A, Mostowska A, Jagodzinski PP. IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection. Vaccine 2013; 31:1766-70; PMID:23462527; http://dx.doi.org/10.1016/j.vaccine.2013.02.023
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu P, Zhu D, Zhang S, Bi Y, Hu Y, Zhou YH. Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life. Vaccine 2012; 30:5708-13; PMID:22824342; http://dx.doi.org/10.1016/j.vaccine.2012.07.010
   PubMed Web of Science ®Google Scholar
• Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet 2011; 20:3893-8; PMID:21764829; http://dx.doi.org/10.1093/hmg/ddr302
   PubMed Web of Science ®Google Scholar
• Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005; 41:1383-90; PMID:15915462; http://dx.doi.org/10.1002/hep.20716
   PubMed Web of Science ®Google Scholar
• Allcock RJ, Martin AM, Price P. The mouse as a model for the effects of MHC genes on human disease. Immunol Today 2000; 21:328-32; PMID:10871872; http://dx.doi.org/10.1016/S0167-5699(00)01654-6
   PubMedGoogle Scholar
• Wrightsman RA, Krassner SM, Watson JD, Manning JE. Role of the H-2s haplotype in survival of mice after infection with Trypanosoma cruzi. Infect Immun 1984; 44:351-4; PMID:6425221
   PubMed Web of Science ®Google Scholar
• Carson S, Trowsdale J. Molecular organization of the class II genes of the human and mouse major histocompatibility complexes. Oxf Surv Eukaryot Genes 1986; 3:63-94; PMID:2855304
   PubMedGoogle Scholar
• Milich DR, Chisari FV. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol 1982; 129:320-5; PMID:6177755
   PubMed Web of Science ®Google Scholar
• Milich DR, Leroux-Roels GG, Chisari FV. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). II. Qualitative characteristics of the humoral immune response to the a, d, and y determinants of HBsAg. J Immunol 1983; 130:1395-400; PMID:6185581
   PubMed Web of Science ®Google Scholar
• von Delwig A, Ramachandra L, Harding CV, Robinson JH. Localization of peptide/MHC class II complexes in macrophages following antigen processing of viable Streptococcus pyogenes. Eur J Immunol 2003; 33:2353-60; PMID:12938211; http://dx.doi.org/10.1002/eji.200323559
   PubMed Web of Science ®Google Scholar
• Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010; 28:445-89; PMID:20192806; http://dx.doi.org/10.1146/annurev-immunol-030409-101212
   PubMed Web of Science ®Google Scholar
• Xu W, Banchereau J. The antigen presenting cells instruct plasma cell differentiation. Front Immunol 2014; 4:504; PMID:24432021; http://dx.doi.org/10.3389/fimmu.2013.00504
   PubMed Web of Science ®Google Scholar
• Chou HY, Lin XZ, Pan WY, Wu PY, Chang CM, Lin TY, Shen HH, Tao MH. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells. J Immunol 2010; 185:5468-75; PMID:20889541; http://dx.doi.org/10.4049/jimmunol.1001875
   PubMed Web of Science ®Google Scholar
• Xu L, Yin W, Sun R, Wei H, Tian Z. Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. Proc Natl Acad Sci U S A 2013; 110:16993-8; PMID:24089450; http://dx.doi.org/10.1073/pnas.1306437110
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang L, Niu W, Wu Y, Zhang J, Meng G. Increased CD4+CD25+FoxP3+ regulatory T cells in the blood of nonresponders after standard hepatitis B surface antigen vaccine immunization. Clin Immunol 2008; 127:265-6; PMID:18304878; http://dx.doi.org/10.1016/j.clim.2007.11.010
   PubMed Web of Science ®Google Scholar
• Goncalves L, Albarran B, Salmen S, Borges L, Fields H, Montes H, Soyano A, Diaz Y, Berrueta L. The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. Virology 2004; 326:20-8; PMID:15262491; http://dx.doi.org/10.1016/j.virol.2004.04.042
   PubMed Web of Science ®Google Scholar
• Akbar SM, Onji M, Inaba K, Yamamura K, Ohta Y. Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology 1993; 78:468-75; PMID:8478028
   PubMed Web of Science ®Google Scholar
• Ayala GM, Gonzalez YB, Lopez FA, Guani GE. The major histocompatibility complex in transplantation. J Transplant 2012; 2012:842141; PMID:22778908
   PubMedGoogle Scholar
• Pride MW, Shi H, Anchin JM, Linthicum DS, LoVerde PT, Thakur A, Thanavala Y. Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide. Proc Natl Acad Sci U S A 1992; 89:11900-4; PMID:1361231; http://dx.doi.org/10.1073/pnas.89.24.11900
   PubMed Web of Science ®Google Scholar
• Krawczyk A, Ludwig C, Jochum C, Fiedler M, Heinemann FM, Shouval D, Roggendorf M, Roggendorf H, Lindemann M. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine. Vaccine 2014; 32:5077-82; PMID:24975813; http://dx.doi.org/10.1016/j.vaccine.2014.06.076
   PubMed Web of Science ®Google Scholar